Kubota Vision Unveils Study Data for Wearable Myopia-Control Device

Kubota Vision announced the publication of a new paper in the journal Scientific Reports: “Effect of short-term peripheral myopic defocus on ocular biometrics using Fresnel “press-on” lenses in humans”.

Kubota Vision Unveils Study Data for Wearable Myopia-Control Device
November 30, 2021
Belkin Vision's Eagle Device for Glaucoma Receives CE Mark Under MDR

Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe.

Belkin Vision's Eagle Device for Glaucoma Receives CE Mark Under MDR
May 17, 2022
LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platform

LayerBio announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 11,185,441 for its OcuRing Drug Delivery Platform.

LayerBio Granted U.S. Patent for OcuRing Drug Delivery Platform
December 02, 2021
Nicox Announces Positive Post Hoc Results from its Clinical Trial for Dry Eye Treatment

Nicox SA revealed positive post-hoc data from its Mississippi Phase 2b clinical trial, finding that once-daily dosed NCX 4251, fluticasone propionate ophthalmic suspension 0.1%, is beneficial in alleviating dry eye symptoms in a subgroup of patients.

Nicox Announces Positive Post Hoc Results from its Clinical Trial for Dry Eye Treatment
December 02, 2021
Revolutionary Drug Treatment For Cataracts Shows Extremely Positive Lab Results

A revolutionary new treatment for cataracts has shown extremely positive results in laboratory tests, giving hope that the condition, which currently can only be cured with surgery, could soon be treated with drugs.

Revolutionary Drug Treatment For Cataracts Shows Extremely Positive Lab Results
May 18, 2022
Study Shows Significant Impact of Omega-3 and Omega-6 Supplement for People with Severe Dry Eye Disease

A novel combination of omega-3 and omega-6 fatty acids taken as a dietary supplement significantly improves symptoms in patients with severe dry eye disease, according to a new study conducted by the Centre for Ocular Research and Education (CORE).

Study Shows Significant Impact of Omega-3 and Omega-6 Supplement for People with Severe Dry Eye Disease
February 10, 2022
Researchers Develop Contact Lens That Monitors Eye Pressure and Administers Glaucoma Drugs

A team of researchers working at Sun Yat-Sen University in China has developed a contact lens that can be used to monitor eye pressure changes and to administer glaucoma drugs when needed.

Researchers Develop Contact Lens That Monitors Eye Pressure and Administers Glaucoma Drugs
May 31, 2022
Kiora: KIO-101 Eye Drop is Safe and Tolerable for Dry Eye Disease

Kiora Pharmaceuticals revealed topline data from its vehicle-controlled, randomized safety study of KIO-101 eye drops.

Kiora: KIO-101 Eye Drop is Safe and Tolerable for Dry Eye Disease
December 15, 2021
Apellis Submits NDA to the FDA for Pegcetacoplan for Geographic Atrophy

Apellis Pharmaceuticals announced that the company has submitted a new drug application (NDA) to the FDA for intravitreal pegcetacoplan, an investigational, targeted C3 therapy, for the treatment of geographic atrophy (GA) secondary to AMD.

Apellis Submits NDA to the FDA for Pegcetacoplan for Geographic Atrophy
June 02, 2022
Nicox Receives Patent for NCX 470 in China, Extending Coverage to 2039

Nicox SA has received a formulation patent for NCX 470, its flagship pharmaceutical candidate in development for patients with open-angle glaucoma or ocular hypertension, from the Chinese National Intellectual Property Administration (CNIPA).

Nicox Receives Patent for NCX 470 in China, Extending Coverage to 2039
February 22, 2022
Daha fazla